Cargando…

Lack of expression of ALK and CD30 in breast carcinoma by immunohistochemistry irrespective of tumor characteristics

CD30 is a member of the tumor necrosis factor family of cell surface receptors normally expressed in lymphocytes, as well as some lymphomas, but has been described in other malignancies. Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that belongs to the insulin receptor superfamily,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nassif, Samer, El-Zaatari, Ziad M., Attieh, Michel, Hijazi, Maya, Fakhreddin, Najla, Aridi, Tarek, Boulos, Fouad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709128/ https://www.ncbi.nlm.nih.gov/pubmed/31393373 http://dx.doi.org/10.1097/MD.0000000000016702

Ejemplares similares

Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective Analysis
por: Tfayli, Arafat, et al.
Publicado: (2017)

Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature
por: Fakhruddin, Najla, et al.
Publicado: (2017)

Shortcomings of ultrasound-guided fine needle aspiration in the axillary management of women with breast cancer
por: Attieh, Michel, et al.
Publicado: (2019)

Lymphoepithelioma-Like Carcinoma of the Breast: A Case Report Unveiling Several Clinical and Histopathological Challenges
por: Aridi, Tarek, et al.
Publicado: (2018)

Plasma cells and lymphoid aggregates in sleeve gastrectomy specimens: Normal or gastritis?
por: Chakhachiro, Zaher, et al.
Publicado: (2020)

BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
por: Fakhruddin, Najla, et al.
Publicado: (2017)

Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report
por: Zhang, Xiao-Ying, et al.
Publicado: (2023)

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
por: Uruga, Hironori, et al.
Publicado: (2018)

Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement
por: Shan, Ling, et al.
Publicado: (2014)

Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry
por: Wang, Jiandong, et al.
Publicado: (2014)

Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry
por: Kato, Yoriko, et al.
Publicado: (2022)

Correlation Between MYCN Gene Status and MYCN Protein Expression in Neuroblastoma: A Pilot Study To Propose the Use of MYCN Immunohistochemistry in Limited-Resource Areas
por: Santiago, Teresa, et al.
Publicado: (2019)

Better method for detection of CD30: Immunohistochemistry or flow cytometry?
por: Higashi, Morihiro, et al.
Publicado: (2021)

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
por: Cha, Yoon Jin, et al.
Publicado: (2014)

Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon
por: Fakhri, Ghina B., et al.
Publicado: (2018)

Signet Ring Cell Carcinoma of the Colon in Young Adults: A Case Report and Literature Review
por: Farraj, Farida Abi, et al.
Publicado: (2019)

Coronary calcification compromises myocardial perfusion irrespective of luminal stenosis
por: Henein, Michael Y., et al.
Publicado: (2016)

Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatment-Naive Advanced ALK-Positive NSCLC
por: Noé, Johannes, et al.
Publicado: (2022)

HIV Patients Developing Primary CNS Lymphoma Lack EBV-Specific CD4(+) T Cell Function Irrespective of Absolute CD4(+) T Cell Counts
por: Gasser, Olivier, et al.
Publicado: (2007)

CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma
por: Fordham, Ashleigh M., et al.
Publicado: (2020)

Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening
por: Lee, Jeeyun, et al.
Publicado: (2015)

Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)
por: Takeuchi, K., et al.
Publicado: (2016)

STAT3 Mutation Is Associated with STAT3 Activation in CD30(+) ALK(−) ALCL
por: Andersson, Emma I., et al.
Publicado: (2020)

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
por: Zhang, Xuchao, et al.
Publicado: (2010)

Lack of CD117 and rare bcl-2 expression in stomach cancer by immunohistochemistry. An immunohistochemical study with review of the literature
por: Mireskandari, Masoud, et al.
Publicado: (2006)

Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients
por: Martinez, Pablo, et al.
Publicado: (2013)

Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required
por: Pickett, Justine L., et al.
Publicado: (2017)

Health effects associated with waterpipe smoking
por: El-Zaatari, Ziad M, et al.
Publicado: (2015)

Lack of Increase in Muscle Mitochondrial Protein Synthesis During the Course of Aerobic Exercise and Its Recovery in the Fasting State Irrespective of Obesity
por: Serrano, Nathan, et al.
Publicado: (2021)

Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
por: Hamadi, Rachelle, et al.
Publicado: (2023)

Granulocyte-colony stimulating factor in decompensated liver cirrhosis: a meta-analysis of four randomized controlled trials
por: Dimachkie, Reem, et al.
Publicado: (2023)

Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer
por: Hout, David R., et al.
Publicado: (2017)

Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status
por: Xiao, Zhiguang, et al.
Publicado: (2014)

The Expression of CD30 Based on Immunohistochemistry Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2015)

Workplace Anger Costs Women Irrespective of Race
por: Marshburn, Christopher K., et al.
Publicado: (2020)

Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
por: Jurmeister, Philipp, et al.
Publicado: (2021)

Primary cutaneous CD 30 (+) ALK (−) anaplastic large cell lymphoma with dermoscopic findings: a case report
por: Uzuncakmak, Tugba K., et al.
Publicado: (2017)

Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative
por: Ma, Di, et al.
Publicado: (2016)

CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
por: Fousek, Kristen, et al.
Publicado: (2020)

Immunohistochemistry
por: HAWES, DEBRA, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h02bb8g1kvqdqaq6vgemnuus8e